Investigator
Michael D. Frakes
NATIONAL BUREAU OF ECONOMIC RESEARCH · funded by NIA
- Companies
- 2
- Grants
- 2
- Non-dilutive funding
- $627k
- First award
- Feb 15, 2023
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
On this record.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- NATIONAL BUREAU OF ECONOMIC RESEARCHMomentum in another area
NeuroGrant-only
- NATIONAL BUREAU OF ECONOMIC RESEARCHMomentum in another area
NeuroGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
The Impacts of Enhanced Drug-Patent Examination
$310kFeb 15, 2023NIANATIONAL BUREAU OF ECONOMIC RESEARCHNIH RePORTER · 11019760 (opens the source filing in a new tab)
- R01
The Impacts of Enhanced Drug-Patent Examination
$317kFeb 15, 2023NIANATIONAL BUREAU OF ECONOMIC RESEARCHNIH RePORTER · 11262855 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources